Proposal aims to build a database of bulk drug traders, improve traceability of imported raw materials, over 70% of which ...

Thanks to a huge generic drug sector, India is widely regarded as the pharmacy of the world--and just a few years ago many of the ingredients going into those drugs were produced within the country.

India, like other countries, has grown dependent on cheap active pharmaceutical ingredients from China. With the COVID-19 outbreak having put pressure on prices and supplies, the country is now doing ...

The global market for active pharmaceutical ingredients (APIs) in 2013 was estimated at US$ 119.7 billion and is projected to grow at a CAGR of 6.5% to a value of US$ 185.9 billion by 2020 The Asian ...

Rating agency ICRA on Monday highlighted the encouraging growth prospects of the Indian active pharmaceutical ingredients (API) industry. ICRA expects the revenues of its sample set of companies to ...

In an interview to Rhythma Kaul, pharmaceuticals export promotion council of India, or Pharmexcil, vice chairman Bhavin Mehta speaks about challenges the country’s pharma exports is likely to face in ...

Mumbai: Softening prices of active pharmaceutical ingredients (API) are likely to stabilise in the months ahead and bring relief to Indian manufacturers, but they will still have to improve their ...

India is the largest provider of generic drugs globally. Indian pharmaceutical industry supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Indian API Market Outlook 2022" report to their offering. According to report on Indian API Market Outlook 2022, the ...

India's startup ecosystem is experiencing unprecedented growth, with fintech innovations at the forefront of this transformation. At the heart of this revolution are fintech APIs (Application ...